We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Affymetrix, Inc. | NASDAQ:AFFX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.01 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant x Filed by a party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement | |
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
¨ | Definitive Proxy Statement | |
x | Definitive Additional Materials | |
¨ | Soliciting Material Pursuant to §240.14a-12 |
Affymetrix, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x | No fee required. | |||
¨ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) |
Title of each class of securities to which transaction applies:
|
|||
(2) |
Aggregate number of securities to which transaction applies:
|
|||
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|||
(4) |
Proposed maximum aggregate value of transaction:
|
|||
(5) |
Total fee paid:
|
|||
¨ | Fee paid previously with preliminary materials. | |||
¨ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
(1) |
Amount previously paid:
|
|||
(2) |
Form, Schedule or Registration Statement No.:
|
|||
(3) |
Filing party:
|
|||
(4) |
Date Filed:
|
Memorandum
DATE: | March 28, 2016 |
Affymetrix, Inc. 3420 Central Expressway Santa Clara, CA 95051 www.affymetrix.com |
||
TO: |
All Affymetrix Employees |
|||
FROM: |
Frank Witney |
|||
SUBJECT: |
Acquisition Update |
Dear Global Affymetrix team,
You may have seen our press release this morning stating that the Affymetrix board reaffirmed its support of our merger with Thermo Fisher and recommended against the Origin Technologies proposal. This conclusion was reached after an extensive investment of time and resources by Affymetrix management and its legal and financial advisors engaging with Origin. The Board carefully considered many factors, as outlined in the press release, and concluded that the merger with Thermo Fisher constituted the highest value proposition reasonably available to Affymetrix stockholders. As a result, we will proceed to a shareholder vote at the Special Stockholder Meeting that is scheduled to reconvene this Thursday March 31 st .
The Senior Leadership Team very much appreciates your continued focus on the task at hand as we come down the home stretch in Q1, as well as your attention, in some cases, to integration planning activities with Thermo Fisher.
Sincerely,
Frank Witney
President & Chief Executive Officer
Important Information for Affymetrix Stockholders
In connection with the proposed merger, Affymetrix has filed a proxy statement with the Securities and Exchange Commission (the SEC). STOCKHOLDERS ARE ADVISED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED WITH THE SEC ON FEBRUARY 24, 2016 BECAUSE IT CONTAINS IMPORTANT INFORMATION. Stockholders may obtain a free copy of the proxy statement and any other relevant documents filed with the SEC from the SECs website at http://www.sec.gov . In addition, stockholders will be able to obtain, without charge, a copy of the proxy statement and other relevant documents at Affymetrix website at investor.Affymetrix.com or by contacting Affymetrix investor relations department via e-mail at investor@affymetrix.com .
Affymetrix and its directors, executive officers and other members of its management and employees as well as Thermo Fisher and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Affymetrix stockholders with respect to the merger. Information about Affymetrix directors and executive officers and their ownership of Affymetrix common stock is set forth in the proxy statement for Affymetrix 2016 Special Meeting of Stockholders, Affymetrix Annual Report on Form 10-K for the fiscal year ended December 31, 2015 and proxy statement for Affymetrix 2015 Annual Meeting of Stockholders. Information about Thermo Fishers directors and executive officers is set forth in the proxy statement for Thermo Fishers 2015 Annual Meeting of Stockholders. Stockholders may obtain additional information regarding the direct and indirect interests of the participants in the solicitation of proxies in connection with the merger, including the interests of Affymetrix directors and executive officers in the merger, which may be different than those of Affymetrix stockholders generally, by reading the proxy statement and other relevant documents regarding the merger, which have been filed with the SEC.
1 Year Affymetrix Chart |
1 Month Affymetrix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions